HomeTrials

Cardiac imaging agent detects ischemia and MI in phase II trial

Early PET scans guide de-escalation of therapy for advanced Hodgkin’s lymphoma

First patient dosed with PyL, a PSMA-targeted PET/CT imaging agent for prostate cancer

Molecular imaging study reveals improved detection of early recurrent prostate cancer

Progenics inks licensing pact with Johns Hopkins University for agent to image prostate cancer using PET scan

Study looks to prevent memory loss before symptoms appear

Using FDG-PET to guide Hodgkin lymphoma treatment

About NMC | Products | Quote | News | Resources | Contact | Sitemap